{"entity":{"id":"emory-winship","kind":"institution","name":"Winship Cancer Institute of Emory University","aka":[],"tldr":"Winship is Georgia's only NCI comprehensive cancer centre; its myeloma programme under Sagar Lonial shaped daratumumab development, Suresh Ramalingam led the FLAURA trial that made osimertinib first-line for EGFR-mutant lung cancer, and it runs one of the South's largest phase 1 units.","summary":"Founded in 1937 and NCI-designated in 2009, Winship achieved comprehensive status in 2017 and is Georgia's only NCI comprehensive centre. Sagar Lonial's myeloma programme has been central to daratumumab and other anti-CD38 and immunomodulatory drug development; Suresh Ramalingam led the FLAURA trial that made osimertinib the first-line standard in EGFR-mutant lung cancer. Kevin Kalinsky led RxPONDER, which defined which node-positive, HR-positive breast cancer patients benefit from chemotherapy. Winship opened a dedicated cancer tower at Emory Midtown in 2023 and runs one of the South's largest phase 1 units.","asOf":"2026-09-09","links":[{"label":"Winship Cancer Institute","url":"https://winshipcancer.emory.edu"},{"label":"Clinical trials","url":"https://winshipcancer.emory.edu/clinical-trials/"},{"label":"PTCOG: particle therapy facilities in operation","url":"https://www.ptcog.site/index.php/facilities-in-operation-public"}],"tags":[],"related":[],"cancers":["multiple-myeloma","nsclc","breast-hr-positive"],"sections":[],"technologies":["proton-therapy","proton-therapy-systems"],"targets":["cd38","egfr"],"drugs":["daratumumab","osimertinib","oncotype-dx"],"companies":["swog","nrg-oncology"],"institutions":[],"pathways":[],"terms":[],"trials":["rxponder"],"people":["deborah-bruner","robert-woodruff","suresh-ramalingam","kevin-kalinsky","sagar-lonial"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Atlanta, GA","country":"US","lat":33.792,"lng":-84.322,"institutionType":"cancer-center","website":"https://winshipcancer.emory.edu","nci":"comprehensive","university":"Emory University","programs":["Multiple myeloma","EGFR-mutant lung cancer (FLAURA)","Breast cancer (RxPONDER)","Phase 1 unit"]},"route":"/institutions/emory-winship/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"technology":[{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"proton-therapy-systems","kind":"technology","name":"Proton therapy machines: cyclotrons, synchrotrons and single-room systems","route":"/technologies/proton-therapy-systems/"}],"target":[{"id":"cd38","kind":"target","name":"CD38","route":"/targets/cd38/"},{"id":"egfr","kind":"target","name":"EGFR","route":"/targets/egfr/"}],"drug":[{"id":"daratumumab","kind":"drug","name":"Daratumumab","route":"/drugs/daratumumab/"},{"id":"oncotype-dx","kind":"drug","name":"Oncotype DX","route":"/drugs/oncotype-dx/"},{"id":"osimertinib","kind":"drug","name":"Osimertinib","route":"/drugs/osimertinib/"}],"company":[{"id":"nrg-oncology","kind":"company","name":"NRG Oncology","route":"/companies/nrg-oncology/"},{"id":"swog","kind":"company","name":"SWOG Cancer Research Network","route":"/companies/swog/"}],"trial":[{"id":"rxponder","kind":"trial","name":"RxPONDER (SWOG S1007)","route":"/trials/rxponder/"}],"person":[{"id":"deborah-bruner","kind":"person","name":"Deborah Watkins Bruner","route":"/people/deborah-bruner/"},{"id":"kevin-kalinsky","kind":"person","name":"Kevin Kalinsky","route":"/people/kevin-kalinsky/"},{"id":"robert-woodruff","kind":"person","name":"Robert W. Woodruff","route":"/people/robert-woodruff/"},{"id":"sagar-lonial","kind":"person","name":"Sagar Lonial","route":"/people/sagar-lonial/"},{"id":"suresh-ramalingam","kind":"person","name":"Suresh S. Ramalingam","route":"/people/suresh-ramalingam/"}],"institution":[{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"}]}}